10 years ago

Oxford Biotrans Secures £2.5 Million Series A Funding

  • Oxford Biotrans, a University of Oxford spin-out company, has raised £2.5 million in Series A funding led by Imperial Innovations

  • The round included participation from existing shareholders IP Group plc and the University of Oxford, as well as new investors Oxford Innovations, Technology EIS Fund, and De Monchy Aromatics

  • The company intends to use the funds to establish purpose-built facilities and expand its team

  • Oxford Biotrans aims to commercialize new specialty chemicals based on its patented enzyme technology

  • Its first product is natural grade nootkatone, the flavor and scent of grapefruit

  • The company has already identified several further flavor product targets and plans to realize scalable, “green”, and economically attractive enzymatic processes for production of these new targets

  • Oxford Biotrans will also explore targets in other market segments.

      • ProblemHealthcare

      "Oxford Biotrans aims to develop scalable and economically viable enzymatic processes for the production of natural flavors and scents, which are currently limited in supply and expensive to produce."

      Solution

      "The company uses patented enzyme technology to produce natural grade nootkatone, the flavor and scent of grapefruit, and plans to apply this technology to create other natural flavors and scents."

      Covered on